Summer Sale

Up to 30% off — ends 7 Aug

ONLY00h00m00s

Get 30% Off

Up to 30% off — ends 7 Aug

ONLY00h00m00s

Tommaso Lorenzo Parigi

University of Birmingham

United Kingdom

This profile is automatically generated from trusted academic sources.

Google Scholar

ORCID

How do I reach out?

Meet Kite AI

Contact this professor

ORCID

Google Scholar

Research Interests

Internal Medicine

50%

Periodontics

40%

Gastroenterology

70%

Inflammatory Bowel Disease

50%

Mucosal Biology

40%

Inflammatory Biology

30%

Endoscopy

20%

Ask ApplyKite AI

Start chatting

How can you help me contact this professor?

What are this professor's research interests?

How should I write an email to this professor?

Articles10

Real‐world use of endoscopic and histological indices in ulcerative colitis: Results of a global survey

Article Link

Year:

2023

Neutrophil-only histological assessment of ulcerative colitis correlates with endoscopic activity and predicts long-term outcomes in a multicenter study

Article Link

Year:

2023

Response to: Correspondence on "PICaSSO Histologic Remission Index (PHRI) in ulcerative colitis: development of a novel simplified histological score for monitoring mucosal healing and predicting clinical outcomes and its applicability in an artificial intelligence system" by Wonget al

Article Link

Year:

2023

Clinical features and management issues of NAFLD-related HCC: what we know so far

Article Link

Year:

2023

Constrained multiple instance learning for ulcerative colitis prediction using histological images

Article Link

Year:

2022

Critical Appraisal of Filgotinib in the Treatment of Ulcerative Colitis: Current Evidence and Place in Therapy

Article Link

Year:

2022

PICaSSO Histologic Remission Index (PHRI) in ulcerative colitis: development of a novel simplified histological score for monitoring mucosal healing and predicting clinical outcomes and its applicability in an artificial intelligence system

Article Link

Year:

2022

Do JAK inhibitors have a realistic future in treating Crohn’s disease?

Article Link

Year:

2022

Evolution and New Horizons of Endoscopy in Inflammatory Bowel Diseases

Article Link

Year:

2022

Anti-integrin drugs in clinical trials for inflammatory bowel disease (IBD): insights into promising agents

Article Link

Year:

2021

Collaborators6

Alessio Aghemo

ITALY

Maria Rescigno

Humanitas University

ITALY

Subrata Ghosh

University of Birmingham

UNITED KINGDOM

Enrico Grisan

Associate Professor in Artificial Intelligence

London South Bank University

UNITED KINGDOM

Nicola Pugliese

Humanitas University

ITALY

Bu'Hussain Hayee

Professor in Gastroenterology

King’s College London

UNITED KINGDOM

How do I reach out?

Meet Kite AI